The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis

Background and Purpose. Since the first case of fecal microbiota transplantation for the treatment of ulcerative colitis was described in the year 1989, there have been an increment of case reports, case series, cohort studies, and randomized controlled trials (RCTs). In this study, we were going to...

Full description

Saved in:
Bibliographic Details
Main Authors: Wai Ching Lam, Chen Zhao, Wen Juan Ma, Liang Yao
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/1287493
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545500497182720
author Wai Ching Lam
Chen Zhao
Wen Juan Ma
Liang Yao
author_facet Wai Ching Lam
Chen Zhao
Wen Juan Ma
Liang Yao
author_sort Wai Ching Lam
collection DOAJ
description Background and Purpose. Since the first case of fecal microbiota transplantation for the treatment of ulcerative colitis was described in the year 1989, there have been an increment of case reports, case series, cohort studies, and randomized controlled trials (RCTs). In this study, we were going to investigate general clinical remission, clinical response, and steroid-free remission of fecal microbiota transplantation. Methods. We searched Ovid Medline, Ovid EMBASE, and Cochrane Library, focusing prospective studies including randomized controlled trials and cohort studies. The outcomes were clinical remission, clinical response, steroid-free remission, and serious adverse events. We used RevMan 5.3 software for meta-analyses. Key Results. A total of 4 RCTs and 2 cohort studies (340 cases from 5 countries) were included. We found that FMT might be more effective than placebo on clinical remission (OR, 3.85 [2.21, 6.7]; P<0.001; I2=0%) and clinical response (OR, 2.75 [1.33, 5.67]; P=0.006; I2=49%), but no statistical difference on steroid-free remission (OR, 2.08 [0.41, 10.5]; P=0.37; I2=69%) and serious adverse events (OR, 2.0 [0.17, 22.97]; P=0.44; I2=0%). Conclusions and Inferences. Fecal microbiota transplantations were associated with significant clinical remission and response in ulcerative colitis patients while there was no significant difference found between FMT and placebo in steroid-free remission. Moreover, a common consensus on the route, volume, timing, preferred donor characteristics, and frequency of fecal administration is necessary to achieve remission.
format Article
id doaj-art-415f9ece06df46059b311937c55b4085
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-415f9ece06df46059b311937c55b40852025-02-03T07:25:30ZengWileyGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/12874931287493The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-AnalysisWai Ching Lam0Chen Zhao1Wen Juan Ma2Liang Yao3School of Chinese Medicine Hong Kong Baptist University Hong Kong, ChinaSchool of Chinese Medicine Hong Kong Baptist University Hong Kong, ChinaEvidence-based Medicine Center, School of Basic Medical Science, Lanzhou University, ChinaSchool of Chinese Medicine Hong Kong Baptist University Hong Kong, ChinaBackground and Purpose. Since the first case of fecal microbiota transplantation for the treatment of ulcerative colitis was described in the year 1989, there have been an increment of case reports, case series, cohort studies, and randomized controlled trials (RCTs). In this study, we were going to investigate general clinical remission, clinical response, and steroid-free remission of fecal microbiota transplantation. Methods. We searched Ovid Medline, Ovid EMBASE, and Cochrane Library, focusing prospective studies including randomized controlled trials and cohort studies. The outcomes were clinical remission, clinical response, steroid-free remission, and serious adverse events. We used RevMan 5.3 software for meta-analyses. Key Results. A total of 4 RCTs and 2 cohort studies (340 cases from 5 countries) were included. We found that FMT might be more effective than placebo on clinical remission (OR, 3.85 [2.21, 6.7]; P<0.001; I2=0%) and clinical response (OR, 2.75 [1.33, 5.67]; P=0.006; I2=49%), but no statistical difference on steroid-free remission (OR, 2.08 [0.41, 10.5]; P=0.37; I2=69%) and serious adverse events (OR, 2.0 [0.17, 22.97]; P=0.44; I2=0%). Conclusions and Inferences. Fecal microbiota transplantations were associated with significant clinical remission and response in ulcerative colitis patients while there was no significant difference found between FMT and placebo in steroid-free remission. Moreover, a common consensus on the route, volume, timing, preferred donor characteristics, and frequency of fecal administration is necessary to achieve remission.http://dx.doi.org/10.1155/2019/1287493
spellingShingle Wai Ching Lam
Chen Zhao
Wen Juan Ma
Liang Yao
The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
Gastroenterology Research and Practice
title The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
title_full The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
title_fullStr The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
title_full_unstemmed The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
title_short The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
title_sort clinical and steroid free remission of fecal microbiota transplantation to patients with ulcerative colitis a meta analysis
url http://dx.doi.org/10.1155/2019/1287493
work_keys_str_mv AT waichinglam theclinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT chenzhao theclinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT wenjuanma theclinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT liangyao theclinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT waichinglam clinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT chenzhao clinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT wenjuanma clinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis
AT liangyao clinicalandsteroidfreeremissionoffecalmicrobiotatransplantationtopatientswithulcerativecolitisametaanalysis